fda glp-1 warning letters september 2025 Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertiser U.S. FDA | FDA is

Clinics that don't prepare you for possibilities aren't prioritizing patient safety

The peptide specifically targets cells that have already undergone senescence, effectively clearing them from tissues without compromising normal cellular function or predisposing tissues to acute damage

Marta reflects honestly on building too much without consulting end users early enough, and how founders need to go and physically talk to their users rather than relying on surveys or assumptions

Combined with vitamin C, which supports collagen production, the result is a more even, radiant complexion over a course of treatments

Therefore, in peri- and post-menopausal patients, rapid or substantial weight loss while on semaglutide may plausibly unmask or intensify GSM symptoms via endocrine and tissue-level changesalthough the specific contribution of semaglutide vs weight loss per se is not established

Results may come sooner for some and later for others, depending on age, lifestyle, baseline growth hormone levels, and dosage